臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

???jsp.browse.items-by-title.jump??? [ ???jsp.browse.general.jump2chinese??? ] [ ???jsp.browse.general.jump2numbers??? ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]

???jsp.browse.items-by-title.enter???

Showing items 446331-446340 of 2348609 (234861 Page(s) Totally)
<< < 44629 44630 44631 44632 44633 44634 44635 44636 44637 44638 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-04T02:36:02Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:33Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-02-02T00:46:57Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏	2022-09-15T01:09:54Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
國家衛生研究院	2015-10	Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy	Chang, LS;Yan, WL;Chang, YW;Yeh, YC;Chen, HW;Leng, CH;Liu, SJ
國立臺灣大學	2007	Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells	沈盈君; 鄭安理; SHEN, YING-CHUN; CHENG, ANN-LII
國家衛生研究院	2015-07	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY
臺大學術典藏	2022-08-19T00:20:46Z	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Lim H.Y.; Kim J.S.; Orlando M.; Chen L.-T.; Chen J.-S.; CHIUN HSU; Oh D.-Y.; Park J.O.
臺大學術典藏	2015	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Oh D.-Y.; Chiun Hsu; Chen J.-S.; Chen L.-T.; Orlando M.; Kim J.S.; Lim H.Y.; Park J.O.; Park J.O.;Oh D.-Y.;Chiun Hsu;Chen J.-S.;Chen L.-T.;Orlando M.;Kim J.S.;Lim H.Y.
臺大學術典藏	2021-01-28T01:06:31Z	Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial	Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M.

Showing items 446331-446340 of 2348609 (234861 Page(s) Totally)
<< < 44629 44630 44631 44632 44633 44634 44635 44636 44637 44638 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52552608 ???header.onlineuser??? : 781 ???header.sponsordeclaration???